News & Updates
Filter by Specialty:
Show Multimedia Only

Nonhormonal drug for hot flash scores big in two phase III trials
02 Nov 2024
byJairia Dela Cruz
The novel neurokinin-1 and -3 receptor antagonist elinzanetant appears to reduce the frequency and severity of vasomotor symptoms (VMS), as well as improve sleep and menopause-related quality of life, as shown in two pivotal phase III trials.
Nonhormonal drug for hot flash scores big in two phase III trials
02 Nov 2024
Dietary intake of n-3 PUFA prevents all-cause, CV deaths in diabetic people
02 Nov 2024
Individuals with prediabetes or diabetes may benefit from increased dietary intake of n-3 polyunsaturated fatty acids (PUFAs), particularly alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA), which help lower the risk of all-cause and cardiovascular mortality, suggests a US study.
Dietary intake of n-3 PUFA prevents all-cause, CV deaths in diabetic people
02 Nov 2024
RSV may worsen clinical outcomes in HF patients
01 Nov 2024
byAudrey Abella
A retrospective analysis presented at HSFA ASM 2024 shows that respiratory syncytial virus (RSV) infection in individuals with heart failure (HF) is associated with greater adverse clinical outcomes.